Daniel Vapnek

Corporate Officer/Principal chez University of California, Santa Barbara

Profil

Dr. Daniel Vapnek is an Advisor at Iguana Healthcare Management LLC.
He was Senior Vice president for Research at Amgen from 1981-1997.
During his tenure, scientists under his direction developed Epogen and Neupogen and discovered the RANK ligand which laid the groundwork for the development of denosumab for the treatment of osteoporosis.
For the past decade, Dr. Vapnek has been an advisor to venture capital funds and involved in several startups including BioArray solutions, which was recently sold to Immucor.
He is currently on The Board of Directors of Medicinova and an Adjunct Professor of Cellular and Molecular Biology at the University of California Santa Barbara.
Prior to joining Amgen, he was Professor of Molecular and Population Biology at the University of Georgia.
Dr. Vapnek received his undergraduate degree from the University of Miami (Florida) and a doctorate degree from the University of Miami (Florida).

Postes actifs de Daniel Vapnek

Sociétés	Poste	Début
University of California, Santa Barbara	Corporate Officer/Principal	-

Anciens postes connus de Daniel Vapnek

Sociétés	Poste	Fin
Avigen, Inc.	Directeur/Membre du Conseil	01/04/2007
Protein Pathways, Inc.	Président	01/11/2004
ASPIRA WOMEN'S HEALTH INC.	Directeur/Membre du Conseil	01/05/2001
AMGEN INC.	Directeur Technique/Scientifique/R&D	31/12/1996
University of Georgia	Corporate Officer/Principal	-

Formation de Daniel Vapnek

University of Miami

Undergraduate Degree